Comparison of Stationary Breast Tomosynthesis and 2-D Digital Mammography in Patients With Known Breast Lesions
Launched by UNC LINEBERGER COMPREHENSIVE CANCER CENTER · Jan 18, 2013
Trial Information
Current as of May 29, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women at least 18 years old.
- • Scheduled for breast biopsy of at least one breast lesion.
- • Lesion detected on mammogram.
- • Symptomatic by patient self-report, patient self-breast exam or clinical exam.
- • Able to provide informed consent.
- Exclusion Criteria:
- • Male. (It is uncommon for men to present for imaging and the overwhelming majority of findings are non-cancerous and do not lead to biopsy; male breast cancer represents \<1% of newly diagnosed breast cancer)
- • Less than 18 years of age.
- • Patient unable to give consent.
- • Institutionalized subject (prisoner or nursing home patient).
- • Any woman who is pregnant or has reason to believe she is pregnant or any woman who is lactating
About Unc Lineberger Comprehensive Cancer Center
The UNC Lineberger Comprehensive Cancer Center is a leading research institution dedicated to advancing cancer treatment and prevention through innovative clinical trials and comprehensive patient care. As a National Cancer Institute-designated comprehensive cancer center, it integrates cutting-edge research, interdisciplinary collaboration, and patient-centered approaches to address diverse oncology challenges. With a commitment to translating scientific discoveries into effective therapies, UNC Lineberger strives to improve outcomes for patients while fostering a robust environment for education and training in cancer research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chapel Hill, North Carolina, United States
Patients applied
Trial Officials
Yueh Z Lee, MD,PhD
Principal Investigator
University of North Carolina, Chapel Hill
Cherie M Kuzmiak, DO
Principal Investigator
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials